NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE American · Medical Devices · USD

Flyte Aviation, Inc. (VTAK) Stock Analysis

Flyte Aviation, Inc. (VTAK) is a Medical Devices stock listed on NYSE American and quoted in US Dollar.

Last Updated: October 20, 2026

VTAK

$0.78

−$0.04 (−4.88%)

Oct 20, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare VTAK with… →

VTAK Key Statistics

As of Oct 20, 2026
Trading
Open
$0.83
Previous Close
$0.82
Day's Range
0.66–0.83
52-Week Range
0.15–31.40
Volume
331.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.51
Valuation
Market Cap
$286.48K
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.15
EPS (ttm)Profit attributable to each share over the last twelve months.
−68.40
Financials (FY)
Revenue (FY)
$819.00K+95.00%
Net Income (FY)
−$17.18M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.90M
1-Year Return
−97.05%
Dividend and dates
Avg Volume
724.55K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 20, 2026, VTAK closed at $0.78, −97.05% over 1 year.

Flyte Aviation, Inc. (VTAK) has a market capitalization of $286.48K.

In fiscal 2025, VTAK reported revenue of $819.00K.

VTAK Stock Return by Calendar Year

Flyte Aviation, Inc. (VTAK) return since Sep 2018: what $10,000 became

1 year
$10,000 $295
−97.05%
5 years
$10,000 $0.03
−99.9997%
Since Sep 2018
$10,000 $0.0002
−99.999998%

If you had invested $10,000 in Flyte Aviation, Inc. (VTAK) at the close on September 27, 2018, the earliest close on record here, it would have been worth $0.0002 at the close on October 20, 2026: −99.999998% in total, −89.17% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−95.74%
2025−78.60%
2024−88.75%
2023−93.21%
2022−92.45%
2021−79.00%
2020−73.70%
2019−85.79%
2018 (partial year)−60.25%

As of October 20, 2026.

VTAK Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$819.00K−$17.18M−2,098.0%
2024$420.00K−$16.64M−3,962.6%
2023$442.00K−$70.57M−15,966.5%
2022$14.00K−$26.87M−191,892.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$819.00K$756.00K−$12.18M−$17.18M−2,098.0%
2024$420.00K$378.00K−$11.24M−$16.64M−3,962.6%
2023$442.00K$412.00K−$17.19M−$70.57M−15,966.5%
2022$14.00K−$147.00K−$22.79M−$26.87M−191,892.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

VTAK Valuation vs Medical Devices Median

Median of 145 stocks
MetricVTAKMedical Devices medianvs median
P/S ratio0.152.530.1x the median

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Flyte Aviation, Inc. (VTAK) at $286.48K. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 17.

The 52-week range on file runs from $0.15 to $31.40. VTAK last closed at $0.78 on October 20, 2026. That is −$0.04 (−4.88%) against the previous close. The latest close sits 428.46% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $819.00K. Against the prior fiscal year total of $420.00K, that is a change of +95.00%. The same year closed with a net loss of $17.18M. Earnings per share on a trailing basis come to −68.4.

Across the 4 fiscal years on file, revenue moves from $14.00K in 2022 to $819.00K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 0.15 times revenue. On price-to-sales that is 0.1 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is −97.05%. Across 5 years the annualized return works out at −92.28%. Beta against the wider market is reported at 0.51. Annualized volatility over the trailing 8 years is 146.65%.

Growth & Income

No dividend is on file for VTAK.

Across the complete calendar years on file, 2020 returned −73.70% and 2023 returned −93.21%. Of the 7 complete calendar years on file, 0 finished higher. So far in 2026 the total return is −95.74%.

Peer Comparison

Flyte Aviation, Inc. (VTAK) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Flyte Aviation, Inc. VTAK $286.48K —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Flyte Aviation, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 20, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Flyte Aviation, Inc.

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.

Visit website →